Personalized survivorship support for rural lung cancer survivors
Official title: Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
Funded at University of Colorado Denver · NIH-11159425 · Data updated 2026-11-12
This program offers personalized survivorship support for rural lung cancer survivors to improve quality of life, reduce stigma, and help people stay connected to care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | July 6, 2021 |
| Project end | March 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $596,589 |
| NIH project number | 5R01CA254734-04 |
| Project ID | NIH-11159425 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are rural lung cancer survivors—especially those in Appalachian Kentucky—who have completed primary treatment and want extra support managing life after cancer.
✕Less likely to help
People currently undergoing intensive active cancer treatment, those with rapidly progressing disease, or those not living in the participating rural regions may not receive benefit from this survivorship-focused program.
What this research studies
You would be offered a tailored survivorship program that uses patient-centered care, shared decision making, and motivational interviewing to support your needs. The program was co-developed with rural community stakeholders and is being delivered through participating lung cancer clinics in Kentucky. People will be randomly assigned to receive the precision survivorship intervention or usual care so researchers can compare outcomes. The team previously ran a large acceptability and feasibility trial across nine Kentucky sites and is now conducting a randomized trial to test the approach more rigorously.
Why it matters
Potential benefit: If successful, this program could improve survivors' quality of life, reduce lung cancer stigma, and increase engagement with follow-up care.
How similar studies have gone: A prior acceptability and feasibility trial with about 140 lung cancer survivors across nine Kentucky clinics showed promise, and this randomized trial builds on that work.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Studts, Jamie L — University of Colorado Denver
- Study coordinator: Studts, Jamie L
Related research
Other NIH-funded projects on the same topics.
-
Improving care for lung cancer survivors in rural communities
This study is all about helping lung cancer survivors in rural Kentucky live better lives by offering personalized care and support, and it’s designed for those who have battled lung cancer and want to be more involved in their recovery journey.
-
Cancer survival in colon and lung cancer: how new therapies and access to care affect outcomes
This grant links state cancer data, insurance claims, and mental health records to study how younger cancer patients use new targeted therapies and what factors influence their survival.
-
Understanding colon and lung cancer survivorship through linked health records
This project links cancer registry, insurance claims, and mental health records to learn how treatments, other health conditions, and access to care affect survival for people with colon and lung cancer, including adults under 65.
-
Bridging cancer center and local doctor care to help childhood cancer survivors keep up with follow-up
A telehealth education program, tailored patient-portal messages, and coordinated outreach to primary care doctors to help childhood cancer survivors stay on track with recommended long-term follow-up care.
-
Improving care for childhood cancer survivors through community partnerships
This study is all about helping kids who have survived cancer get the follow-up care they need by using telehealth to connect them with their doctors, making it easier for them to understand and manage their health after treatment.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.